Opioid Crisis Causes Prescription Denials for Xanax and Adderall Patients

Patients suffering from anxiety and sleep disorders are being denied prescriptions for medications such as Xanax and Adderall due to a cap on the number of controlled substances that pharmacies are allowed to dispense, as part of a 2021 settlement with three of the nation’s largest pharmaceutical manufacturers over the opioid epidemic. Pharmacists are being forced to turn away patients who rely on prescription medications, and some are sent to independent pharmacies that haven’t yet reached the threshold on how many orders they can fill. The cap is affecting the ability of independent pharmacists to aid those who are suffering from attention-deficit hyperactivity disorder (ADHD) and were prescribed drugs such as Concerta and Ritalin.